T1	Pharmacological_substance 0 9	Linezolid
N1000 	Reference T1 MeSH:D000069349	Linezolid
T2	Disorder 36 52	optic neuropathy
N1 	Reference T2 UMLS:C3887709	optic neuropathy
T3	Disorder 54 69	lactic acidosis
N2 	Reference T3 UMLS:C0001125	lactic acidosis
T4	Disorder 75 93	serotonin syndrome
N3 	Reference T4 UMLS:C0024586	serotonin syndrome
N4 	Reference T4 UMLS:C0699828	serotonin syndrome
T5	Pharmacological_substance 95 104	Linezolid
N1001 	Reference T5 MeSH:D000069349	Linezolid
T6	Pharmacological_substance 111 144	oxazolidinone antibacterial agent
T7	Disorder 167 191	gram-positive infections
N5 	Reference T7 UMLS:C3714514	gram-positive infections
T8	Disorder 348 363	lactic acidosis
N6 	Reference T8 UMLS:C0001125	lactic acidosis
T9	Disorder 380 396	optic neuropathy
N7 	Reference T9 UMLS:C3887709	optic neuropathy
T10	Disorder 402 420	serotonin syndrome
N8 	Reference T10 UMLS:C0024586	serotonin syndrome
N9 	Reference T10 UMLS:C0699828	serotonin syndrome
T11	Pharmacological_substance 495 504	linezolid
N1002 	Reference T11 MeSH:D000069349	linezolid
T12	Disorder 528 543	lactic acidosis
N10 	Reference T12 UMLS:C0001125	lactic acidosis
T13	Disorder 584 602	serotonin syndrome
N11 	Reference T13 UMLS:C0024586	serotonin syndrome
N12 	Reference T13 UMLS:C0699828	serotonin syndrome
T14	Disorder 639 644	Death
N13 	Reference T14 UMLS:C1306577	Death
T15	Disorder 688 703	lactic acidosis
N14 	Reference T15 UMLS:C0001125	lactic acidosis
T16	Disorder 739 757	serotonin syndrome
N15 	Reference T16 UMLS:C0024586	serotonin syndrome
N16 	Reference T16 UMLS:C0699828	serotonin syndrome
T17	Disorder 817 833	optic neuropathy
N17 	Reference T17 UMLS:C3887709	optic neuropathy
T18	Disorder 897 918	peripheral neuropathy
N18 	Reference T18 UMLS:C0031117	peripheral neuropathy
T19	Pharmacological_substance 920 929	Linezolid
N1003 	Reference T19 MeSH:D000069349	Linezolid
T20	Pharmacological_substance 1032 1041	linezolid
N1004 	Reference T20 MeSH:D000069349	linezolid
T21	Disorder 1112 1128	optic neuropathy
N19 	Reference T21 UMLS:C3887709	optic neuropathy
T22	Disorder 21 31	peripheral
T26	Disorder 198 219	minor adverse effects
N20 	Reference T26 UMLS:C0879626	minor adverse effects
T27	Disorder 265 288	serious adverse effects
N21 	Reference T27 UMLS:C0879626	serious adverse effects
T29	Disorder 365 375;386 396	peripheral neuropathy
N22 	Reference T29 UMLS:C0031117	peripheral neuropathy
T30	Disorder 422 432;443 453	Peripheral neuropathy
N23 	Reference T30 UMLS:C0031117	Peripheral neuropathy
T31	Disorder 437 453	optic neuropathy
N24 	Reference T31 UMLS:C3887709	optic neuropathy
T35	Disorder 1097 1107;1118 1128	peripheral neuropathy
T38	Coreferring_mention 990 1011	these adverse effects
T43	Speculation_cue 1064 1070	should
